Journal of Physical Chemistry A, Vol.114, No.3, 1581-1591, 2010
Laser Spectroscopy of Conformationally Constrained alpha/beta-Peptides: Ac-ACPC-Phe-NHMe and Ac-Phe-ACPC-NHMe
Single-conformation ultraviolet and infrared spectra have been recorded under the isolated molecule conditions of a supersonic expansion for three conformationally constrained alpha/beta-peptides, AC-L-Phe-ACPC-NHMe (alpha(L)beta(ACPC)), Ac-ACPC-L-Phe-NHMe (beta(ACPC)alpha(L)), and Ac-ACPC-D-Phe-NHMe (beta(ACPC)alpha(D)). These three molecules are close analogues of the hAla-containing alpha/beta-peptide counterparts Ac-L-Phe-beta(3)-hAla-NHMe, Ac-beta(3)-hAla-L-Phe-NHMe, and Ac-beta(3)-hAla-D-Phe-NHMe, which have been Studied recently by James et al. (J. Am. Chem. Soc. 2009, 131, 6574). Incorporation of the beta-amino acid traits-2-aminocyclopentanecarboxylic acid (ACPC) constrains the beta-peptide backbone via the cyclopentane ring, producing clear changes in the conformational preferences relative to the unconstrained analogues. The conformational control is manifested most obviously in the complete absence of C6 H-bonded rings, which were dominant in the unconstrained alpha/beta-peptides. The most stable C6 ring structure (C6a) in the absence of the ACPC ring cannot be formed in its presence, while a secondary C6 ring (C6b) has its energy dustabilized by similar to 20 kJ/mol. In alpha(L)beta(ACPC), the preference for C5 structures ill the N-terminal position, combined with the strong preference for C8 structures in the beta-peptide subunit, leads to the observation of two C5/C8 bifurcated double ring conformers. Both C8/C7 sequential double rings and C11 single rings are observed in beta(ACPC)alpha(L). and beta(ACPC)alpha(D). Here, the ACPC ring selectively stabilizes the C8a ring over other possible C8 structures. Finally, the combined evidence from IR and UV spectra lead to tentative assignments for diastereomeric pairs, exhibiting small but understandable shifts in the IR and UV spectra induced by the change in chirality at the alpha-peptide chiral center.